Business
New Patent
New Patent.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n \n \n RNS Number : 9873N\n AorTech International PLC\n 27 May 2020\n \n \n \n \n AorTech International plc \n \n \n (\"AorTech\" or the \"Company\") \n \n \n \n \n \n New Patent \n \n \n \n \n \n AorTech International plc (AIM: AOR.L), the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon\n ™\n ), is pleased to announce that the United States Patent and Trademark Office has notified AorTech that its Application Number 15/995,050 will issue as Patent Number 10,676,560 entitled \"BIOSTABLE POLYURETHANES\" on 9th June 2020. \n \n \n \n \n \n The invention relates to a biostable polyurethane or polyurea comprising: (a) a soft segment comprising a polysiloxane of the general formula disclosed in the Patent; and (b) greater than 0 and less than 40 wt % of a hard segment which is a reaction product of a diisocyanate and a linear difunctional chain extender, processes for their preparation and their use in the manufacture of biomaterials, implantable medical devices and polymeric heart valves. \n \n \n \n \n \n Bill Brown, Chairman of AorTech, said\n : \"We are delighted that at the same time as major steps are being made in the development of our ElastEon\n ™\n enabled medical devices, our Intellectual Property portfolio relating to the ElastEon™ family of world class biostable polymers has been expanded further by the grant of this latest US patent. We currently anticipate reaching the significant milestone of commencing animal testing on the ElastEon\n ™\n sealed graft in the coming weeks.\" \n \n \n \n \n \n For further information contact:\n \n \n \n \n \n AorTech International plc \n \n \n Bill Brown, Chairman Tel: +44 (0) 77 3071 8296\n \n \n David Richmond, CEO Tel:...